Key result
The PAI-1 promoter 4G allele had a higher prevalence in patients with myocardial infarction before age 45 than in population-based controls.
Case-Control
Answers are grounded in this paper and cite their sources.
Increased plasminogen-activator inhibitor 1 (PAI-1) activity is a common finding in patients with coronary heart disease. Here we provide evidence for an independent, etiological role of PAI-1 in myocardial infarction. The 4G allele of a recently described common 4/5-guanine-tract (4G/5G) polymorphism in the PAI-1 promoter is associated with higher plasma PAI-1 activity. The prevalence of the 4G allele is significantly higher in patients with myocardial infarction before the age of 45 than in population-based controls (allele frequencies of 0.63 vs. 0.53). Both alleles bind a transcriptional activator, whereas the 5G allele also binds a repressor protein to an overlapping binding site. In the absence of bound repressor, the basal level of PAI-1 transcription is increased.
No takes yet. Share an insight, caveat, or question.
Eriksson et al. (1995) conducted a case-control in Myocardial infarction. 4G allele of the PAI-1 promoter 4G/5G polymorphism vs. 5G allele / population-based controls was evaluated on 4G allele frequency in myocardial infarction patients vs. controls. The PAI-1 promoter 4G allele had a higher prevalence in patients with myocardial infarction before age 45 than in population-based controls.
Synapse has enriched 10 related papers. Consider them for comparative context: